Tag Archive for: novel inhaled cystic fibrosis therapy

NanoBio to Present Preclinical Data on Its Nanoemulsion Adjuvanted Intranasal RSV Vaccine and Novel Inhaled Cystic Fibrosis Therapy at 52nd Annual ICAAC Meeting

ANN ARBOR, Mich. (September 10, 2012) – NanoBio Corporation announced today it will present data from two separate preclinical studies at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting currently underway in San Francisco. Read more